Scope of the Study
Nutrigenomics is defined as basically interaction of nutrition and genes in order to the treatment of disease. It is also known as nutritional genomics. Numerous benefits of using nutrigenomics testing such as allows them to make positive changes to their lifestyle, shifting the focus from disease management to disease prevention and health promotion and other benefits. Introduction and development of direct to consumer nutrigenomics kits and rising intake of specialized food and diet are some of the major drivers which are propelling the growth of the market. The market for the nutrigenomics is expected to register a CAGR of over 5.2% during the forecast period.
The market study is being classified by Type (Reagents & kits and Services), by Application (Obesity, Diabetes, Anti-Aging and Chronic Diseases) and major geographies with country level break-up.
Cura Integrative Medicine (Australia), NutraGene (United States), XCODE Life Science Pvt. Ltd. (India), Nutrigenomix (Canada), WellGen Inc. (United States), Genomix Nutrition Inc. (United States), Royal DSM (Netherlands), BASF SE (Germany), Danone S.A (France) and GeneSmart (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Unilever (United Kingdom), Genova Diagnostics (United States), NutriGenomix, Inc. (Canada), Metagenics, Inc. (United States) and WellGen, Inc. (United States).
The market is fragmented with numerous players focusing on technique and quality of the product due to which the global nutrigenomics market can witness an upsurge in the forecast period. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Nutrigenomics market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Nutrigenomics market by Type, Application and Region.
On the basis of geography, the market of Nutrigenomics has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
- Rising Healthcare Expenditure, and Encouraging Government Support for Research and Development
- Increasing Awareness of Health and Treatments
- Increased Spending On Healthcare and a Demand for Holistic Treatments
- Technology Advancement in Nutrigenomics
- Issue related to High Cost Associated with the Treatment
- Increasing Demand from Emerging Economies such as China and India
- Lack of Physicians Qualified to Provide Nutrigenomics Treatments
Market Leaders and their expansionary development strategies
In April 2018, the Prenetics Limited (Hong Kong) Company has acquired DNAFit Ltd (United Kingdom) Company for more than USD 10 Million, which serves customers with pharmacogenomics, nutrigenomics, cancer, and reproductive health tests. Hence, this acquisition will help in strengthening the position of the company.
Key Target AudienceNutrigenomics Testing Companies, Research and Development (R&D) Companies, Research Organization, Federal Agencies and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase